MD Anderson and Rakuten Medical Announce Strategic Alliance to Advance Illuminox Platform for Cancer Treatments
June 05, 2020
June 05, 2020
HOUSTON, Texas, June 5 -- The University of Texas's MD Anderson Cancer Center issued the following news release:
The University of Texas MD Anderson Cancer Center and Rakuten Medical, Inc. announced a strategic alliance collaboration agreement to advance the development of new cancer therapies based on Rakuten Medical's proprietary IlluminoxTM technology platform.
Under the terms of the agreement, Rakuten Medical and MD Anderson will collaborate to conduct studies based . . .
The University of Texas MD Anderson Cancer Center and Rakuten Medical, Inc. announced a strategic alliance collaboration agreement to advance the development of new cancer therapies based on Rakuten Medical's proprietary IlluminoxTM technology platform.
Under the terms of the agreement, Rakuten Medical and MD Anderson will collaborate to conduct studies based . . .